LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
88452-8
|
Babesia microti 18S rRNA gene
|
PrThr
|
Pt
|
Bld
|
Ord
|
Non-probe.amp.tar
|
MICRO
| 1 |
Babesia microti 18S rRNA gene [Presence] in Blood by NAA with non-probe detection
|
B microti 18S rRNA Bld Ql NAA+non-probe
| null |
ACTIVE
|
2.64
|
2.64
|
88453-6
|
HIV 1 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA
|
PrThr
|
Pt
|
Ser/Plas/Bld^Donor
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
HIV 1 RNA+Hepatitis C virus RNA+Hepatitis B virus DNA [Presence] in Serum, Plasma or Blood from Donor by NAA with probe detection
|
HIV1+HCV+HBV SerPlBld Donr NAA+prb
| null |
ACTIVE
|
2.64
|
2.73
|
88454-4
|
Mumps virus Ab.IgG+IgM
|
Imp
|
Pt
|
CSF
|
Ord
|
IF
|
MICRO
| 1 |
Mumps virus IgG+IgM Ab [Interpretation] in Cerebral spinal fluid Qualitative by Immunofluorescence
|
MuV IgG+IgM CSF IF-Imp
| null |
ACTIVE
|
2.64
|
2.65
|
88455-1
|
California encephalitis virus Ab.IgG & IgM panel
|
-
|
Pt
|
Ser
|
-
|
IF
|
PANEL.MICRO
| 1 |
California encephalitis virus Ab.IgG and IgM panel - Serum by Immunofluorescence
|
CEV Ab.IgG & IgM panel Ser IF
| null |
ACTIVE
|
2.64
|
2.65
|
88456-9
|
California encephalitis virus Ab.IgG+IgM
|
Imp
|
Pt
|
Ser
|
Ord
|
IF
|
MICRO
| 1 |
California encephalitis virus IgG+IgM Ab [Interpretation] in Serum Qualitative by Immunofluorescence
|
CEV IgG+IgM Ser IF-Imp
| null |
ACTIVE
|
2.64
|
2.65
|
88457-7
|
Herpes simplex virus 1 Ab.IgM
|
PrThr
|
Pt
|
CSF
|
Ord
|
IF
|
MICRO
| 1 |
Herpes simplex virus 1 IgM Ab [Presence] in Cerebral spinal fluid by Immunofluorescence
|
HSV1 IgM CSF Ql IF
| null |
ACTIVE
|
2.64
|
2.65
|
88458-5
|
Mumps virus Ab.IgG & IgM panel
|
-
|
Pt
|
CSF
|
-
|
IF
|
PANEL.MICRO
| 1 |
Mumps virus Ab.IgG and IgM panel - Cerebral spinal fluid by Immunofluorescence
|
Mumps virus Ab.IgG & IgM panel CSF IF
| null |
ACTIVE
|
2.64
|
2.65
|
88459-3
|
Serotonin release 1.0 IU/mL heparin.low molecular weight
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
SERO
| 1 |
Serotonin release 1.0 IU/mL heparin.low molecular weight [Units/volume] in Serum
|
SRA 1.0 IU/mL LMW heparin Ser-aCnc
| null |
ACTIVE
|
2.64
|
2.64
|
88460-1
|
Serotonin release 50 IU/mL heparin.low molecular weight
|
ACnc
|
Pt
|
Ser
|
Qn
| null |
SERO
| 1 |
Serotonin release 50 IU/mL heparin.low molecular weight [Units/volume] in Serum
|
SRA 50 IU/mL LMW heparin Ser-aCnc
| null |
ACTIVE
|
2.64
|
2.64
|
88461-9
|
Babesia microti & divergens+MO-1 strain & duncani 18S rRNA gene panel
|
-
|
Pt
|
Bld
|
-
|
Non-probe.amp.tar
|
PANEL.MICRO
| 1 |
Babesia microti and B. divergens+MO-1 and B. duncani 18S rRNA gene panel - Blood by NAA with non-probe detection
|
Babesia sp 18S rRNA Pnl Bld NAA+non-pr
| null |
ACTIVE
|
2.64
|
2.64
|
88462-7
|
Carbapenem
|
Susc
|
Pt
|
Isolate
|
OrdQn
| null |
ABXBACT
| 1 |
Carbapenem [Susceptibility]
|
Carbapenem Susc Islt
| null |
ACTIVE
|
2.64
|
2.66
|
88463-5
|
OASIS E - Skin Conditions - SOC, ROC
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS E - Skin Conditions - SOC, ROC [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.72
|
88464-3
|
OASIS D - Integumentary status - discharge from agency
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS D - Integumentary status - discharge from agency [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.67
|
88465-0
|
Types and sources of assistance - start of care or resumption of care
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
Types and sources of assistance - start of care or resumption of care [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.67
|
88466-8
|
Care management - start of care or resumption of care
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
Deprecated Care management - start of care or resumption of care [CMS Assessment]
| null | null |
DEPRECATED
|
2.64
|
2.7
|
88467-6
|
Care management - discharge from agency
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
Care management - discharge from agency [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.67
|
8846-8
|
Oxygen saturation
|
MFr
|
Pt
|
Heart.ventricle.right.outflow tract
|
Qn
| null |
HEMODYN.MOLEC
| 2 |
Right ventricular outflow tract Oxygen saturation
|
SaO2 % RVOT
| null |
ACTIVE
|
1.0h(3)
|
2.4
|
88468-4
|
Types and sources of assistance - discarge from agency
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
Types and sources of assistance - discarge from agency [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.67
|
88469-2
|
How much has your chest pain, chest tightness or angina limited your enjoyment of life over the past 4W
|
Find
|
4W
|
^Patient
|
Ord
|
SAQ
|
SURVEY.GNHLTH
| 4 |
How much has your chest pain, chest tightness or angina limited your enjoyment of life over the past 4 weeks [SAQ]
| null |
Copyright © 1995-2005 John Spertus, MD, MPH. Used with permission.
|
ACTIVE
|
2.64
|
2.64
|
884-7
|
ABO & Rh group
|
Type
|
Pt
|
BldC
|
Nom
| null |
BLDBK
| 1 |
ABO and Rh group [Type] in Capillary blood
|
ABO + Rh BldC
| null |
ACTIVE
|
1.0
|
2.72
|
88470-0
|
Quality of life score
|
Score
|
Pt
|
^Patient
|
Qn
|
SAQ
|
SURVEY.GNHLTH
| 4 |
Quality of life score [SAQ]
| null |
Copyright © 1995-2005 John Spertus, MD, MPH. Used with permission.
|
ACTIVE
|
2.64
|
2.64
|
88471-8
|
Symptom frequency score
|
Score
|
Pt
|
^Patient
|
Qn
|
SAQ
|
SURVEY.GNHLTH
| 4 |
Symptom frequency score [SAQ]
| null |
Copyright © 1995-2005 John Spertus, MD, MPH. Used with permission.
|
ACTIVE
|
2.64
|
2.64
|
88472-6
|
Physical limitation score
|
Score
|
Pt
|
^Patient
|
Qn
|
SAQ
|
SURVEY.GNHLTH
| 4 |
Physical limitation score [SAQ]
| null |
Copyright © 1995-2005 John Spertus, MD, MPH. Used with permission.
|
ACTIVE
|
2.64
|
2.64
|
88473-4
|
If you had to spend the rest of your life with your chest pain, chest tightness or angina the way it is right now, how would you feel about this
|
Find
|
Pt
|
^Patient
|
Ord
|
SAQ
|
SURVEY.GNHLTH
| 4 |
If you had to spend the rest of your life with your chest pain, chest tightness or angina the way it is right now, how would you feel about this [SAQ]
| null |
Copyright © 1995-2005 John Spertus, MD, MPH. Used with permission.
|
ACTIVE
|
2.64
|
2.64
|
88474-2
|
Overall summary score
|
Score
|
Pt
|
^Patient
|
Qn
|
SAQ
|
SURVEY.GNHLTH
| 4 |
Overall summary score [SAQ]
| null |
Copyright © 1995-2005 John Spertus, MD, MPH. Used with permission.
|
ACTIVE
|
2.64
|
2.64
|
88475-9
|
How many times have you had to take nitroglycerin (nitroglycerin tablets or spray) for your chest pain, chest tightness or angina on average over the past 4W
|
Find
|
4W
|
^Patient
|
Ord
|
SAQ
|
SURVEY.GNHLTH
| 4 |
How many times have you had to take nitroglycerin (nitroglycerin tablets or spray) for your chest pain, chest tightness or angina over the past 4 weeks [SAQ]
| null |
Copyright © 1995-2005 John Spertus, MD, MPH. Used with permission.
|
ACTIVE
|
2.64
|
2.65
|
8847-6
|
Oxygen saturation
|
MFr
|
Pt
|
Heart.ventricle.right
|
Qn
| null |
HEMODYN.MOLEC
| 2 |
Right ventricular Oxygen saturation
|
SaO2 % RV
| null |
ACTIVE
|
1.0h(3)
|
2.4
|
88476-7
|
How many times have you had chest pain, chest tightness or angina on average over the past 4W
|
Find
|
4W
|
^Patient
|
Ord
|
SAQ
|
SURVEY.GNHLTH
| 4 |
How many times have you had chest pain, chest tightness or angina over the past 4 weeks [SAQ]
| null |
Copyright © 1995-2005 John Spertus, MD, MPH. Used with permission.
|
ACTIVE
|
2.64
|
2.64
|
88477-5
|
Lifting or moving heavy objects limited by chest pain, chest tightness or angina over the past 4W
|
Find
|
4W
|
^Patient
|
Ord
|
SAQ
|
SURVEY.GNHLTH
| 4 |
Lifting or moving heavy objects limited by chest pain, chest tightness or angina over the past 4 weeks [SAQ]
| null |
Copyright © 1995-2005 John Spertus, MD, MPH. Used with permission.
|
ACTIVE
|
2.64
|
2.65
|
88478-3
|
Gardening, vacuuming, or carrying groceries limited by chest pain, chest tightness or angina over the past 4W
|
Find
|
4W
|
^Patient
|
Ord
|
SAQ
|
SURVEY.GNHLTH
| 4 |
Gardening, vacuuming, or carrying groceries limited by chest pain, chest tightness or angina over the past 4 weeks [SAQ]
| null |
Copyright © 1995-2005 John Spertus, MD, MPH. Used with permission.
|
ACTIVE
|
2.64
|
2.65
|
88479-1
|
Seattle Angina Questionnaire - 7 items
|
-
|
Pt
|
^Patient
|
-
|
SAQ
|
PANEL.SURVEY.GNHLTH
| 4 |
Seattle Angina Questionnaire - 7 items [SAQ]
| null |
Copyright © 1995-2005 John Spertus, MD, MPH. Used with permission.
|
ACTIVE
|
2.64
|
2.67
|
88480-9
|
Walking indoors on level ground limited by chest pain, chest tightness or angina over the past 4W
|
Find
|
4W
|
^Patient
|
Ord
|
SAQ
|
SURVEY.GNHLTH
| 4 |
Walking indoors on level ground limited by chest pain, chest tightness or angina over the past 4 weeks [SAQ]
| null |
Copyright © 1995-2005 John Spertus, MD, MPH. Used with permission.
|
ACTIVE
|
2.64
|
2.65
|
88481-7
|
Activity limitations panel
|
-
|
-
|
^Patient
|
-
|
SAQ
|
PANEL.SURVEY.GNHLTH
| 4 |
Activity limitations panel [SAQ]
| null |
Copyright © 1995-2005 John Spertus, MD, MPH. Used with permission.
|
ACTIVE
|
2.64
|
2.64
|
88482-5
|
Functional abilities and goals - admission
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
Functional abilities and goals - admission [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.67
|
88483-3
|
Functional abilities and goals - discharge
|
-
|
3D
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
Functional abilities and goals - discharge [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.67
|
8848-4
|
Oxygen saturation
|
MFr
|
Pt
|
Coronary sinus
|
Qn
| null |
HEMODYN.MOLEC
| 2 |
Coronary sinus Oxygen saturation
|
SaO2 % CS
| null |
ACTIVE
|
1.0h(3)
|
2.4
|
88484-1
|
OASIS D - Functional abilities and goals - follow-up
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS D - Functional abilities and goals - follow-up [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.67
|
88485-8
|
OASIS D - Self-care - follow-up performance
|
-
|
RptPeriod
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS D - Self-care - follow-up performance during assessment period [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.7
|
88486-6
|
OASIS D - Mobility - follow-up performance
|
-
|
RptPeriod
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS D - Mobility - follow-up performance during assessment period [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.72
|
88487-4
|
OASIS D - Patient history and diagnoses - start of care or resumption of care
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS D - Patient history and diagnoses - SOC or ROC [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.67
|
88488-2
|
OASIS E - Diagnoses and symptom control
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS E - Diagnoses and symptom control [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.72
|
88489-0
|
OASIS E - Primary diagnosis
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS E - Primary diagnosis [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.72
|
88490-8
|
OASIS E - Other diagnoses
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS E - Other diagnoses [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.72
|
88491-6
|
OASIS D - Patient history and diagnoses - follow-up
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS D - Patient history and diagnoses - follow-up [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.64
|
8849-2
|
Oxygen saturation
|
MFr
|
Pt
|
Ductus arteriosus
|
Qn
| null |
HEMODYN.MOLEC
| 2 |
Ductus arteriosus Oxygen saturation
|
SaO2 % DA
| null |
ACTIVE
|
1.0h(3)
|
2.4
|
88492-4
|
OASIS D - Sensory status - start of care or resumption of care or follow-up
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS D - Sensory status - SOC or ROC or follow-up [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.67
|
88493-2
|
OASIS D - Integumentary status - start of care or resumption of care
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
Deprecated OASIS D - Integumentary status - SOC or ROC [CMS Assessment]
| null | null |
DEPRECATED
|
2.64
|
2.72
|
88494-0
|
OASIS E - Current number of unhealed pressure injuries at each stage - SOC, ROC, FU
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS E - Current number of unhealed pressure injuries at each stage - SOC, ROC, FU [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.72
|
88495-7
|
OASIS D - Respiratory status - start of care or resumption of care
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS D - Respiratory status - SOC or ROC [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.67
|
88496-5
|
OASIS E - Bladder and Bowel - SOC, ROC
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS E - Bladder and Bowel - SOC, ROC [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.72
|
88497-3
|
OASIS E - Bladder and Bowel - DC
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS E - Elimination status - discharge from agency [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.72
|
88498-1
|
OASIS D - Neuro & emotional & behavioral status - start of care or resumption of care
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS D - Neuro and emotional and behavioral status - SOC or ROC [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.67
|
88499-9
|
OASIS D - ADL and IADLs - start of care or resumption of care
|
-
|
RptPeriod
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS D - ADL and IADLs - SOC or ROC during assessment period [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.7
|
88-5
|
Cefmetazole
|
Susc
|
Pt
|
Isolate
|
OrdQn
|
MIC
|
ABXBACT
| 1 |
Cefmetazole [Susceptibility] by Minimum inhibitory concentration (MIC)
|
Cefmetazole Islt MIC
| null |
ACTIVE
|
1.0
|
2.19
|
8850-0
|
Oxygen saturation
|
MFr
|
Pt
|
Vena cava.inferior
|
Qn
| null |
HEMODYN.MOLEC
| 2 |
Inferior vena cava Oxygen saturation
|
SaO2 % IVC
| null |
ACTIVE
|
1.0h(3)
|
2.4
|
88500-4
|
OASIS D - ADL and IADLs - discharge from agency
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS D - ADL and IADLs - discharge from agency [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.67
|
88501-2
|
OASIS D - Medications - start of care or resumption of care
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS D - Medications - start of care or resumption of care [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.72
|
88502-0
|
OASIS E - Preferences for Customary Routine Activities - DC
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS E - Preferences for Customary Routine Activities - DC [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.72
|
88503-8
|
OASIS D - Therapy need and plan of care
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS D - Therapy need and plan of care [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.67
|
88504-6
|
OASIS D - Data items collected at inpatient facility admission or agency discharge only - transfer
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS D - Data items collected at inpatient facility admission or agency discharge only - transfer [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.67
|
88505-3
|
OASIS D - Data items collected at inpatient facility admission or agency discharge only - discharge from agency - death at home
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS D - Data items collected at inpatient facility admission or agency discharge only - discharge from agency - death at home [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.67
|
88506-1
|
OASIS D - Data items collected at inpatient facility admission or agency discharge only - discharge from agency
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS D - Data items collected at inpatient facility admission or agency discharge only - discharge from agency [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.67
|
88507-9
|
OASIS D - Sensory status - discharge from agency
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS D - Sensory status - discharge from agency [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.67
|
88508-7
|
OASIS D - Current number of unhealed pressure injuries at each stage - discharge from agency
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS D - Current number of unhealed pressure injuries at each stage - discharge from agency [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.67
|
88509-5
|
Helicobacter pylori 23S rRNA clarithromycin resistance mutation
|
Prid
|
Pt
|
Isolate/Specimen
|
Nom
|
Molgen
|
ABXBACT
| 1 |
Helicobacter pylori 23S rRNA clarithromycin resistance mutation [Identifier] by Molecular method
|
H pylori 23S clarithro res mut Islt/Spm
| null |
ACTIVE
|
2.64
|
2.65
|
88510-3
|
Natural killer cell cytotoxicity.30:1 effector to target cell ratio/Positive control
|
RelACnc
|
Pt
|
Bld MC
|
Qn
| null |
HEM/BC
| 1 |
Natural killer cell cytotoxicity.30:1 effector to target cell ratio/Positive control in Blood mononuclear cells
|
NK cytotox.30:1 E:T/Pos cntrl Bld MC
| null |
ACTIVE
|
2.64
|
2.64
|
88511-1
|
Natural killer cell cytotoxicity.0.9:1 effector to target cell ratio/Positive control
|
RelACnc
|
Pt
|
Bld MC
|
Qn
| null |
HEM/BC
| 1 |
Natural killer cell cytotoxicity.0.9:1 effector to target cell ratio/Positive control in Blood mononuclear cells
|
NK cytotox.0.9:1 E:T/Pos cntrl Bld MC
| null |
ACTIVE
|
2.64
|
2.64
|
88512-9
|
Natural killer cell cytotoxicity.15:1 effector to target cell ratio/Positive control
|
RelACnc
|
Pt
|
Bld MC
|
Qn
| null |
HEM/BC
| 1 |
Natural killer cell cytotoxicity.15:1 effector to target cell ratio/Positive control in Blood mononuclear cells
|
NK cytotox.15:1 E:T/Pos cntrl Bld MC
| null |
ACTIVE
|
2.64
|
2.7
|
88513-7
|
Natural killer cell cytotoxicity.7.5:1 effector to target cell ratio/Positive control
|
RelACnc
|
Pt
|
Bld MC
|
Qn
| null |
HEM/BC
| 1 |
Natural killer cell cytotoxicity.7.5:1 effector to target cell ratio/Positive control in Blood mononuclear cells
|
NK cytotox.7.5:1 E:T/Pos cntrl Bld MC
| null |
ACTIVE
|
2.64
|
2.7
|
88514-5
|
Natural killer cell cytotoxicity.1.88:1 effector to target cell ratio/Positive control
|
RelACnc
|
Pt
|
Bld MC
|
Qn
| null |
HEM/BC
| 1 |
Natural killer cell cytotoxicity.1.88:1 effector to target cell ratio/Positive control in Blood mononuclear cells
|
NK cytotox.1.88:1 E:T/Pos cntrl Bld MC
| null |
ACTIVE
|
2.64
|
2.7
|
88515-2
|
Natural killer cell cytotoxicity.3.75:1 effector to target cell ratio/Positive control
|
RelACnc
|
Pt
|
Bld MC
|
Qn
| null |
HEM/BC
| 1 |
Natural killer cell cytotoxicity.3.75:1 effector to target cell ratio/Positive control in Blood mononuclear cells
|
NK cytotox.3.75:1 E:T/Pos cntrl Bld MC
| null |
ACTIVE
|
2.64
|
2.7
|
88516-0
|
Gastrointestinal pathogens identified
|
Prid
|
Pt
|
XXX
|
Nom
|
Probe.amp.tar
|
MICRO
| 1 |
Gastrointestinal pathogens identified in Specimen by NAA with probe detection
|
GI pathogens Spec NAA+probe
| null |
ACTIVE
|
2.64
|
2.69
|
88517-8
|
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells^^corrected for background
|
ACnc
|
Pt
|
Bld
|
Qn
| null |
MICRO
| 1 |
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] corrected for background in Blood
|
M TB IFN-g CD4+CD8+ bckgrnd cor Bld-aCnc
| null |
ACTIVE
|
2.64
|
2.73
|
8851-8
|
Oxygen saturation
|
MFr
|
Pt
|
Pulmonary artery.left
|
Qn
| null |
HEMODYN.MOLEC
| 2 |
Left pulmonary artery Oxygen saturation
|
SaO2 % PA-L
| null |
ACTIVE
|
1.0h(3)
|
2.54
|
88518-6
|
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells
|
ACnc
|
Pt
|
Bld
|
Qn
| null |
MICRO
| 1 |
Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
|
M TBIFN-g CD4+ CD8+T-cells Bld-aCnc
| null |
ACTIVE
|
2.64
|
2.64
|
88519-4
|
KIT gene.c.2447A>T
|
PrThr
|
Pt
|
Bld/Tiss
|
Ord
|
Molgen
|
MOLPATH.MUT
| 1 |
KIT gene c.2447A>T [Presence] in Blood or Tissue by Molecular genetics method
|
KIT c.2447A>T Bld/T Ql
| null |
ACTIVE
|
2.64
|
2.73
|
88520-2
|
OASIS D - Medications - discharge from agency
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
OASIS D - Medications - discharge from agency [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.67
|
88521-0
|
IRF-PAI v2.0 - Staff assessment for mental status
|
-
|
3D
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
IRF-PAI v2.0 - Staff assessment for mental status [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.69
|
88522-8
|
IRF-PAI v2.0 - Hearing, speech, and vision - admission
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
IRF-PAI v2.0 - Hearing, speech, and vision - admission [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.69
|
88523-6
|
IRF-PAI v2.0 - Quality indicators - admission
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
IRF-PAI v2.0 - Quality indicators - admission [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.69
|
88524-4
|
IRF-PAI v2.0 - Cognitive patterns - admission
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
IRF-PAI v2.0 - Cognitive patterns - admission [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.69
|
88525-1
|
IRF-PAI v2.0 - Quality indicators - discharge
|
-
|
Pt
|
^Patient
|
-
|
CMS Assessment
|
PANEL.SURVEY.CMS
| 4 |
IRF-PAI v2.0 - Quality indicators - discharge [CMS Assessment]
| null | null |
ACTIVE
|
2.64
|
2.64
|
8852-6
|
Oxygen saturation
|
MFr
|
Pt
|
Pulmonary artery.main
|
Qn
| null |
HEMODYN.MOLEC
| 2 |
Main pulmonary artery Oxygen saturation
|
SaO2 % MPA
| null |
ACTIVE
|
1.0h(3)
|
2.4
|
88526-9
|
Guidance for percutaneous biopsy
|
Find
|
Pt
|
Chest>Lung.right
|
Doc
|
CT
|
RAD
| 2 |
CT Guidance for biopsy of Lung - right
|
CT Guided Lung-R Bx
| null |
ACTIVE
|
2.64
|
2.64
|
88527-7
|
Respiratory syncytial virus
|
PrThr
|
Pt
|
Cornea/Conjunctiva
|
Ord
|
Organism specific culture
|
MICRO
| 1 |
Respiratory syncytial virus [Presence] in Cornea or Conjunctiva by Organism specific culture
|
RSV Corn/Cnjt Ql Cult
| null |
ACTIVE
|
2.64
|
2.72
|
88528-5
|
Respiratory syncytial virus RNA
|
PrThr
|
Pt
|
Cornea/Conjunctiva
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
Respiratory syncytial virus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
|
RSV RNA Corn/Cnjt Ql NAA+probe
| null |
ACTIVE
|
2.64
|
2.64
|
88529-3
|
Parainfluenza virus RNA
|
PrThr
|
Pt
|
Cornea/Conjunctiva
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
Parainfluenza virus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
|
HPIV RNA Corn/Cnjt Ql NAA+probe
| null |
ACTIVE
|
2.64
|
2.64
|
88530-1
|
Parainfluenza virus 4 RNA
|
PrThr
|
Pt
|
Cornea/Conjunctiva
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
Parainfluenza virus 4 RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
|
HPIV4 RNA Corn/Cnjt Ql NAA+probe
| null |
ACTIVE
|
2.64
|
2.64
|
88531-9
|
Parainfluenza virus identified
|
Prid
|
Pt
|
Cornea/Conjunctiva
|
Nom
|
Organism specific culture
|
MICRO
| 1 |
Parainfluenza virus identified in Cornea or Conjunctiva by Organism specific culture
|
HPIV Corn/Cnjt Cult
| null |
ACTIVE
|
2.64
|
2.64
|
88532-7
|
Human metapneumovirus Identified
|
Prid
|
Pt
|
Cornea/Conjunctiva
|
Nom
|
Organism specific culture
|
MICRO
| 1 |
Human metapneumovirus identified in Cornea or Conjunctiva by Organism specific culture
|
hMPV Corn/Cnjt Cult
| null |
ACTIVE
|
2.64
|
2.64
|
88533-5
|
Adenovirus DNA
|
PrThr
|
Pt
|
Cornea/Conjunctiva
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
Adenovirus DNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
|
HAdV DNA Corn/Cnjt Ql NAA+probe
| null |
ACTIVE
|
2.64
|
2.64
|
8853-4
|
Oxygen saturation
|
MFr
|
Pt
|
Pulmonary artery.right
|
Qn
| null |
HEMODYN.MOLEC
| 2 |
Right pulmonary artery Oxygen saturation
|
SaO2 % PA-R
| null |
ACTIVE
|
1.0h(3)
|
2.54
|
88534-3
|
Human metapneumovirus RNA
|
PrThr
|
Pt
|
Cornea/Conjunctiva
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
Human metapneumovirus RNA [Presence] in Cornea or Conjunctiva by NAA with probe detection
|
hMPV RNA Corn/Cnjt Ql NAA+probe
| null |
ACTIVE
|
2.64
|
2.64
|
88535-0
|
Cytomegalovirus DNA
|
PrThr
|
Pt
|
Bld.dot
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
Cytomegalovirus DNA [Presence] in DBS by NAA with probe detection
|
CMV DNA DBS Ql NAA+probe
| null |
ACTIVE
|
2.64
|
2.64
|
88536-8
|
Varicella zoster virus DNA
|
PrThr
|
Pt
|
Asp
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
Varicella zoster virus DNA [Presence] in Aspirate by NAA with probe detection
|
VZV DNA Aspirate Ql NAA+probe
| null |
ACTIVE
|
2.64
|
2.64
|
88537-6
|
Enterovirus identified
|
Prid
|
Pt
|
Pericard fld
|
Nom
|
Organism specific culture
|
MICRO
| 1 |
Enterovirus identified in Pericardial fluid by Organism specific culture
|
EV Pcar Cult
| null |
ACTIVE
|
2.64
|
2.64
|
88538-4
|
Enterovirus RNA
|
PrThr
|
Pt
|
Pericard fld
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
Enterovirus RNA [Presence] in Pericardial fluid by NAA with probe detection
|
EV RNA Pcar Ql NAA+probe
| null |
ACTIVE
|
2.64
|
2.64
|
88539-2
|
Adenovirus DNA
|
PrThr
|
Pt
|
Stool
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
Adenovirus DNA [Presence] in Stool by NAA with probe detection
|
HAdV DNA Stl Ql NAA+probe
| null |
ACTIVE
|
2.64
|
2.64
|
885-4
|
Am Ab
|
PrThr
|
Pt
|
Ser/Plas^BPU
|
Ord
| null |
BLDBK
| 1 |
Am Ab [Presence] in Serum or Plasma from Blood product unit
|
Am Ab SerPl BPU Ql
| null |
ACTIVE
|
1.0
|
2.56
|
88540-0
|
Enterovirus RNA
|
PrThr
|
Pt
|
Asp
|
Ord
|
Probe.amp.tar
|
MICRO
| 1 |
Enterovirus RNA [Presence] in Aspirate by NAA with probe detection
|
EV RNA Aspirate Ql NAA+probe
| null |
ACTIVE
|
2.64
|
2.64
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.